|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 348.00 EUR | +1.61% |
|
-0.57% | -2.66% |
| May. 11 | Virbac continues decline despite positive recommendation |  |
| Apr. 17 | Virbac: 2026 starts on strong footing |  |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 17.34x | 2.26x | 1.5x | 1.96x | 9.78x | 12.01x | 0.5% | 3.38B | |
| 12.29x | 8.94x | 1.62x | 4.1x | 9.35x | 10.57x | 2.72% | 33.36B | |
| 284.35x | 1.86x | -2.41x | 2.98x | 15.03x | 17.6x | -.--% | 12.07B | |
| 9.35x | 1.37x | 0.06x | 1.35x | 5.02x | 6.56x | 2.81% | 4.62B | |
| 53.39x | 2.44x | 0.34x | - | - | - | 0.65% | 1.98B | |
| 29.02x | 1.94x | 0.5x | 3.49x | 12.51x | 18.23x | -.--% | 1.69B | |
| 12.74x | 3.38x | 0.12x | 1.22x | 7.25x | 8.59x | 1.51% | 1.28B | |
| 16.2x | 1.47x | 1.51x | 2.05x | 9.85x | 15.12x | 1.9% | 1.06B | |
| 33.75x | 1.18x | 1.76x | - | - | - | 0.44% | 1.02B | |
| 14.76x | 1.23x | -3.56x | 1.04x | 4.92x | 6.97x | 1.32% | 941M | |
| 12.27x | 1.33x | 0.88x | - | - | - | - | 862M | |
| 19.66x | 2.12x | -1.57x | - | - | - | 1.04% | 663M | |
| 16.67x | - | 0.02x | - | - | - | - | 558M | |
| 20.94x | 1.39x | -2.83x | - | - | - | - | 529M | |
| 26.44x | 0.64x | 0.13x | 2.06x | 9.85x | 19.58x | 1.71% | 471M | |
| 65x | 2.02x | -2.16x | 2.55x | 14.16x | 18.55x | 1.66% | 307M | |
| Average | 40.26x | 2.24x | -0.25x | 2.28x | 9.77x | 13.38x | 1.25% | 4.05B | |
| Weighted average by Cap. | 65.71x | 5.53x | 0.46x | 3.35x | 10.21x | 12.09x | 1.82% |
- Stock Market
- Stocks
- VIRP Stock
- Sector Virbac
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
